GENETHERA INC

2021 Q3 Form 10-Q Financial Statement

#000147793221008184 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets $1.020K $12.32K
YoY Change -91.72% 885.6%
Inventory
Prepaid Expenses $1.022K
Receivables
Other Receivables
Total Short-Term Assets $1.022K $12.32K
YoY Change -91.7% -91.28%
LONG-TERM ASSETS
Property, Plant & Equipment $6.600K $11.88K
YoY Change -44.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $6.600K $11.88K
YoY Change -44.44%
TOTAL ASSETS
Total Short-Term Assets $1.022K $12.32K
Total Long-Term Assets $6.600K $11.88K
Total Assets $7.622K $24.20K
YoY Change -68.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $81.07K $81.07K
YoY Change 0.0%
Accrued Expenses $7.173M $6.672M
YoY Change 7.51%
Deferred Revenue
YoY Change
Short-Term Debt $83.80K $80.30K
YoY Change 4.36%
Long-Term Debt Due $721.0K $710.2K
YoY Change 1.51%
Total Short-Term Liabilities $8.059M $7.544M
YoY Change 6.83% 757.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.059M $7.544M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $8.065M $7.544M
YoY Change 6.91% 757.08%
SHAREHOLDERS EQUITY
Retained Earnings -$32.00M
YoY Change
Common Stock $30.97K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.051M -$7.534M -$7.260M
YoY Change
Total Liabilities & Shareholders Equity $7.622K $24.20K
YoY Change -68.5%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28571255 shares
CY2021Q3 us-gaap Cash
Cash
0 USD
CY2020Q4 us-gaap Cash
Cash
0 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1022 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1022 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1022 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1022 USD
CY2021Q3 gnth Automobile Trucks
AutomobileTrucks
26400 USD
CY2020Q4 gnth Automobile Trucks
AutomobileTrucks
26400 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19800 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15840 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6600 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10560 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
0 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
0 USD
CY2021Q3 us-gaap Assets
Assets
7622 USD
CY2020Q4 us-gaap Assets
Assets
11582 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
81070 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
81070 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7172865 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6798920 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
25800 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
25800 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
58000 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
54500 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
720969 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
731796 USD
CY2021Q3 us-gaap Liabilities
Liabilities
8064704 USD
CY2020Q4 us-gaap Liabilities
Liabilities
7692087 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30971255 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24071255 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
30971 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
24071 USD
CY2021Q3 gnth Common Stock To Be Issued
CommonStockToBeIssued
53572 USD
CY2020Q4 gnth Common Stock To Be Issued
CommonStockToBeIssued
53572 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23834776 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23475776 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31996440 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31259962 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-8051082 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-7680504 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7622 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-8051082 USD
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
349500 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11582 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
124440 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-8051082 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
154900 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
378081 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
255028 USD
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
349500 USD
CY2021Q3 us-gaap Depreciation
Depreciation
1320 USD
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
198800 USD
CY2021Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
116500 USD
CY2020Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
116500 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-6920998 USD
us-gaap Net Income Loss
NetIncomeLoss
-613426 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-243866 USD
CY2020Q3 us-gaap Depreciation
Depreciation
1320 USD
us-gaap Depreciation
Depreciation
3960 USD
us-gaap Depreciation
Depreciation
3960 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
242220 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
272720 USD
us-gaap Operating Expenses
OperatingExpenses
731541 USD
us-gaap Operating Expenses
OperatingExpenses
608488 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-242220 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-272720 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-731541 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-608488 USD
CY2021Q3 us-gaap Other Expenses
OtherExpenses
1646 USD
CY2020Q3 us-gaap Other Expenses
OtherExpenses
1646 USD
us-gaap Other Expenses
OtherExpenses
4938 USD
us-gaap Other Expenses
OtherExpenses
4938 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
0 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1646 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1646 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4938 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4938 USD
CY2021Q3 us-gaap Other Income
OtherIncome
0 USD
CY2020Q3 us-gaap Other Income
OtherIncome
0 USD
us-gaap Other Income
OtherIncome
0 USD
us-gaap Other Income
OtherIncome
0 USD
CY2021Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
0 USD
CY2020Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
0 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
0 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
0 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-243866 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-274366 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-736479 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-613426 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-243866 USD
us-gaap Net Income Loss
NetIncomeLoss
-613426 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.01
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.03
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.02
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27756635 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35902602 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25352148 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36030002 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-8012017 USD
CY2021Q3 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
6000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-7260059 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-274366 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-7534425 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-7680504 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
365900 USD
us-gaap Net Income Loss
NetIncomeLoss
-736479 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-7534425 USD
us-gaap Net Income Loss
NetIncomeLoss
-613426 USD
gnth Shares Cancelled
SharesCancelled
0 USD
gnth Shares Cancelled
SharesCancelled
26790 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3960 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3960 USD
gnth Shares Issued For Services
SharesIssuedForServices
359900 USD
gnth Shares Issued For Services
SharesIssuedForServices
-11833 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-12323 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
0 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
0 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-31556 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
373945 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
633080 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1327 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5309 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
gnth Reduction In Loans To Shareholders
ReductionInLoansToShareholders
-10827 USD
gnth Reduction In Loans To Shareholders
ReductionInLoansToShareholders
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
9500 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1327 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5309 USD
CY2020Q4 us-gaap Cash
Cash
0 USD
CY2019Q4 us-gaap Cash
Cash
5309 USD
CY2021Q3 us-gaap Cash
Cash
0 USD
CY2020Q3 us-gaap Cash
Cash
0 USD
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The consolidated financial statements include GeneThera, Inc. and its wholly owned subsidiary GeneThera, Inc. (Colorado) (collectively, the “Company”). The Company had a long-standing research collaboration with GTI Research.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is a biotechnology company that develops molecular assays and therapeutics for the detection and treatment for COVID-19 and other zoonotic diseases.</p>
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30971255 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior period amounts have been reclassified to conform to current period presentation.</p>
CY2021Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1500000 shares
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
55500 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31996440 USD
CY2021Q3 gnth Working Capital
WorkingCapital
-8057682 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6600 USD
gnth Other Maintenance Services
OtherMaintenanceServices
0 USD
gnth Other Maintenance Services
OtherMaintenanceServices
11225 USD
CY2021Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
5842123 USD
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
5338900 USD
CY2021Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
97248 USD
CY2020Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
252546 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1233494 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1207474 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7172865 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6798920 USD
CY2021Q3 gnth Debt Instrument Interest Rate Percentage
DebtInstrumentInterestRatePercentage
0.08 pure
CY2021Q3 gnth Outstanding Principal
OutstandingPrincipal
54500 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
366000 USD
CY2020Q4 gnth Outstanding Principal
OutstandingPrincipal
54500 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3500 USD
CY2021Q3 gnth Debt Instrument Interest Rate Percentage
DebtInstrumentInterestRatePercentage
0.08 pure
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24071255 shares

Files In Submission

Name View Source Status
0001477932-21-008184-index-headers.html Edgar Link pending
0001477932-21-008184-index.html Edgar Link pending
0001477932-21-008184.txt Edgar Link pending
0001477932-21-008184-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gnth-20210930.xsd Edgar Link pending
gnth-20210930_cal.xml Edgar Link unprocessable
gnth-20210930_def.xml Edgar Link unprocessable
gnth-20210930_lab.xml Edgar Link unprocessable
gnth-20210930_pre.xml Edgar Link unprocessable
gthr_10q.htm Edgar Link pending
gthr_10qimg1.jpg Edgar Link pending
gthr_10q_htm.xml Edgar Link completed
gthr_ex311.htm Edgar Link pending
gthr_ex312.htm Edgar Link pending
gthr_ex321.htm Edgar Link pending
gthr_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending